In the case of autosomal dominant polycystic kidney disease (ADPKD), CRISPR was used to delete the PKD2 gene, facilitating a deeper understanding of the disease’s pathogenesis [188]. The gene discussed is PKD2; the disease is autosomal dominant polycystic kidney disease.